176 related articles for article (PubMed ID: 31490413)
1. Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma.
Zhang G; Wu B; Wang X; Li J
Medicine (Baltimore); 2019 Sep; 98(36):e17083. PubMed ID: 31490413
[TBL] [Abstract][Full Text] [Related]
2. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
3. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
Zhang G; Wu B; Wang X; Li J
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
[TBL] [Abstract][Full Text] [Related]
4. Association of esophageal adenocarcinoma with other subsequent primary cancers.
Das A; Thomas S; Zablotska LB; Neugut AI; Chak A
J Clin Gastroenterol; 2006; 40(5):405-11. PubMed ID: 16721221
[TBL] [Abstract][Full Text] [Related]
5. Trends in esophageal cancer incidence by histology, United States, 1998-2003.
Trivers KF; Sabatino SA; Stewart SL
Int J Cancer; 2008 Sep; 123(6):1422-8. PubMed ID: 18546259
[TBL] [Abstract][Full Text] [Related]
6. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies.
Ahsan H; Neugut AI; Gammon MD
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):779-82. PubMed ID: 9332759
[TBL] [Abstract][Full Text] [Related]
7. Changing pattern of esophageal cancer incidence in New Mexico.
Vega KJ; Jamal MM
Am J Gastroenterol; 2000 Sep; 95(9):2352-6. PubMed ID: 11007241
[TBL] [Abstract][Full Text] [Related]
8. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database.
Cooper SC; Trudgill NJ
Cancer Causes Control; 2012 Jun; 23(6):819-25. PubMed ID: 24251326
[TBL] [Abstract][Full Text] [Related]
9. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
10. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
[TBL] [Abstract][Full Text] [Related]
13. Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database.
Gharzai L; Verma V; Denniston KA; Bhirud AR; Bennion NR; Lin C
PLoS One; 2016; 11(7):e0158916. PubMed ID: 27428362
[TBL] [Abstract][Full Text] [Related]
14. Nomograms for predicting survival in early-onset esophageal cancer.
Shi M; Tang JW; Cao ZR
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):437-446. PubMed ID: 33121317
[No Abstract] [Full Text] [Related]
15. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
Islami F; DeSantis CE; Jemal A
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
[TBL] [Abstract][Full Text] [Related]
16. Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis.
Tustumi F; Bernardo WM; da Rocha JRM; Szachnowicz S; Seguro FC; Bianchi ET; Sallum RAA; Cecconello I
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859394
[TBL] [Abstract][Full Text] [Related]
17. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
18. The Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis.
Rosemurgy A; Wilfong C; Craigg D; Co F; Sucandy I; Ross S
Am Surg; 2019 Sep; 85(9):944-948. PubMed ID: 31638504
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological features of esophageal cancer. Squamous cell carcinoma versus adenocarcinoma.
Henry MA; Lerco MM; Ribeiro PW; Rodrigues MA
Acta Cir Bras; 2014 Jun; 29(6):389-93. PubMed ID: 24919048
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]